I am a
Home I AM A Search Login

Papers of the Week

Papers: 24 Feb 2024 - 1 Mar 2024

2024 Feb 27



A randomized, open-label, 5-period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and liquid nasal spray DHE in healthy adults.


Lipton RB, Albrecht D, Bermudez M, Hu J, Hussey E, Levy J


To compare the safety and pharmacokinetics (PK) of dihydroergotamine (DHE) after administration of intranasal DHE powder (STS101), liquid nasal spray (LNS) DHE mesylate, and intramuscular (IM) DHE mesylate injection in healthy participants.